bioDAOs, Longevity, and DeSci | Heinrich Tessendorf, Molecule

In today's episode, we are talking with Heinrich Tessendorf, Community and Marketing Manager at Molecule, where biotech meets web3, building the infrastructure to fund early-stage biopharma research using blockchain. Heinrich was supporting VitaDAO community-owned collective funding early-stage longevity research - at its early phase, taking care of Community & Awareness.

—

Follow Heinrich’s Linkedin: https://www.linkedin.com/in/heintess/

Follow Heinrich’s Twitter: https://twitter.com/Heintess_GM

Follow Piotr’s Twitter: https://twitter.com/Piotr_Saczuk

Follow Piotr’s LinkedIn: https://www.linkedin.com/in/piotr-saczuk-0347521bb/

Subscribe on Apple: shorturl.at/IY019

Subscribe on Spotify: shorturl.at/fqxZ8

Subscribe Lightnode’s Website: https://www.saczukpiotr.xyz
Subscribe Lightnode’s LinkedIn: https://www.linkedin.com/company/lightnode-podcast/

—

Resources

Molecule Web: https://www.molecule.to/

VitaDAO Web: https://www.vitadao.com/

Molecule Twitter: https://twitter.com/Molecule_dao

VitaDAO Twitter: https://twitter.com/vita_dao

Molecule LinkedIn: https://www.linkedin.com/company/molecule-protocol/

VitaDAO LinkedIn: https://www.linkedin.com/company/vitadao/

—

Aleph Zero powers this show.

Aleph Zero is a layer 1 public, permissionless blockchain with private smart contracts that ensures scalability, low transaction fees, instant finality, and optimal security. It's powered by a novel consensus protocol and the WASM-based technology stack.

—

Disclaimer: All statements made on Lightnode are not to be interpreted as financial advice or recommendations to buy or sell securities or tokens. The content of this podcast is purely for informational purposes. Views shared by the host, guests, or any contributors are strictly their personal opinions. Piotr and any podcast participants may have holdings in the entities, funds, or initiatives discussed.